Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to -$306000.0.

  • Lemaitre Vascular's Other Non Operating Income fell 25148.51% to -$306000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$295000.0, marking a year-over-year decrease of 22938.6%. This contributed to the annual value of -$125000.0 for FY2024, which is 6019.11% up from last year.
  • As of Q3 2025, Lemaitre Vascular's Other Non Operating Income stood at -$306000.0, which was down 25148.51% from $247000.0 recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Other Non Operating Income registered a high of $384000.0 during Q4 2022, and its lowest value of -$425000.0 during Q1 2023.
  • Over the past 5 years, Lemaitre Vascular's median Other Non Operating Income value was -$40000.0 (recorded in 2022), while the average stood at -$49315.8.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first surged by 359090.91% in 2022, then plummeted by 96250.0% in 2023.
  • Quarter analysis of 5 years shows Lemaitre Vascular's Other Non Operating Income stood at -$11000.0 in 2021, then surged by 3590.91% to $384000.0 in 2022, then crashed by 70.05% to $115000.0 in 2023, then plummeted by 306.96% to -$238000.0 in 2024, then fell by 28.57% to -$306000.0 in 2025.
  • Its Other Non Operating Income was -$306000.0 in Q3 2025, compared to $247000.0 in Q2 2025 and $2000.0 in Q1 2025.